Association of adiponectin and metabolic syndrome in adolescents: the caspian- III study
暂无分享,去创建一个
[1] Vandana S. Raman,et al. Metabolic syndrome in children and adolescents. , 2017, Translational pediatrics.
[2] M. Abu-Farha,et al. Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs , 2014, Cardiovascular Diabetology.
[3] L. Kolonel,et al. Ethnic differences in serum adipokine and C-reactive protein levels: the multiethnic cohort , 2014, International Journal of Obesity.
[4] R. Bayoumi,et al. Association of adiponectin promoter variants with traits and clusters of metabolic syndrome in Arabs: family-based study. , 2013, Gene.
[5] J. Vieira,et al. Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects , 2013, Cardiovascular Diabetology.
[6] K. Blaslov,et al. Relationship between Adiponectin Level, Insulin Sensitivity, and Metabolic Syndrome in Type 1 Diabetic Patients , 2013, International journal of endocrinology.
[7] S. Yusuf,et al. Causal Relationship between Adiponectin and Metabolic Traits: A Mendelian Randomization Study in a Multiethnic Population , 2013, PloS one.
[8] G. Vilahur,et al. Mechanisms of Chronic State of Inflammation as Mediators That Link Obese Adipose Tissue and Metabolic Syndrome , 2013, Mediators of inflammation.
[9] S. Grundy,et al. Metabolic Risk Susceptibility in Men Is Partially Related to Adiponectin/Leptin Ratio , 2013, Journal of obesity.
[10] Y. Matsuzawa,et al. Association of adiponectin with blood pressure in healthy people , 2013, Clinical endocrinology.
[11] R. Wildman,et al. Race-ethnic differences in adipokine levels: the Study of Women's Health Across the Nation (SWAN). , 2012, Metabolism: clinical and experimental.
[12] R. Kelishadi,et al. Methodology and Early Findings of the Third Survey of CASPIAN Study: A National School-based Surveillance of Students’ High Risk Behaviors , 2012, International journal of preventive medicine.
[13] G. Reaven,et al. The metabolic syndrome: time to get off the merry‐go‐round? , 2011, Journal of internal medicine.
[14] Lawrence Joseph,et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.
[15] J. Flynn,et al. Relationship Between Adiponectin and Ambulatory Blood Pressure in Obese Adolescents , 2009, Pediatric Research.
[16] F. Greenway,et al. Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006. , 2009, Archives of pediatrics & adolescent medicine.
[17] M. Forouzanfar,et al. First Nationwide Study of the Prevalence of the Metabolic Syndrome and Optimal Cutoff Points of Waist Circumference in the Middle East , 2009, Diabetes Care.
[18] P. Scherer,et al. Adiponectin, Cardiovascular Function, and Hypertension , 2008, Hypertension.
[19] W. Garvey,et al. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease , 2007, Current opinion in lipidology.
[20] L. Gilardini,et al. Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. , 2006, Atherosclerosis.
[21] Y. Kesäniemi,et al. Low plasma adiponectin concentration is an indicator of the metabolic syndrome. , 2006, European journal of endocrinology.
[22] G. Sweeney,et al. Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes. , 2006, Biochemical Society transactions.
[23] Herbert Tilg,et al. Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.
[24] N. Chu,et al. Relationship between plasma adiponectin levels and metabolic risk profiles in Taiwanese children. , 2005, Obesity research.
[25] T. Kadowaki,et al. Adiponectin and adiponectin receptors. , 2005, Endocrine reviews.
[26] R. Martos,et al. Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. , 2005, Diabetes & metabolism.
[27] S. Ishibashi,et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. , 2003, Metabolism: clinical and experimental.
[28] A. Shirahata,et al. Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. , 2003, Obesity research.
[29] M. Cnop,et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex , 2003, Diabetologia.
[30] M. Stumvoll,et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. , 2003, Diabetes.
[31] G. Yoshino,et al. Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. , 2002, Diabetes care.
[32] L. Groop,et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.
[33] E. Rimm,et al. Plasma leptin concentrations and obesity in relation to insulin resistance syndrome components among school children in Taiwan—The Taipei Children Heart Study , 2000, International Journal of Obesity.
[34] T. Funahashi,et al. Molecular Mechanism of Metabolic Syndrome X: Contribution of Adipocytokines · Adipocyte‐derived Bioactive Substances , 1999, Annals of the New York Academy of Sciences.
[35] H. Minuk,et al. Metabolic syndrome. , 2005, Journal of insurance medicine.